Cleveland Clinic creates venture arm to maximize results of spinoff companies
Cleveland Clinic has created a new entity to collaborate with Cleveland Clinic Innovations to help build its pipeline of startups into successful, sustainable companies.
Cleveland Clinic Innovations helps turn medical breakthrough inventions into products and companies. Since it was created in 2000, CCI has issued over 850 patents and executed more than 500 licenses on medical devices and techniques. The new department within CCI, Cleveland Clinic Ventures, will help raise funds to get innovative ideas to market and to maximize the performance of spinoff companies.
Cleveland Clinic Innovations Realigns Structure, Adds Two Execs
Cleveland Clinic Innovations (CCI), the commercialization arm of Cleveland Clinic, has announced a restructuring and appointed two new executives. The restructuring elevates the role of Cleveland Clinic Ventures, with the goal of putting added focus on spinning off companies and raising funds to get those companies launched.
A Cleveland Clinic spinoff is trying to get ahead with a mouth guard that helps detect concussions
A Cleveland Clinic spinoff based in suburban Minneapolis is raising money to continue to develop a head impact-monitoring mouth guard that aims to reduce undetected concussions.
Clinic venture arm hopes to assist innovation work
Cleveland Clinic is creating a department to complement and, it hopes, enhance the work that the system's Cleveland Clinic Innovations arm has been doing for years.
The new entity, Cleveland Clinic Ventures, will operate in tandem with Innovations, which works to turn medical breakthrough inventions into products and companies. Leaders say that through the realigned structure, Ventures will offer a renewed and added focus to efforts to spin off companies and to raise funds that help get ideas up and running all the way to market.
Cleveland HeartLab Adds New Patent to its Extensive Intellectual Property Position for the Myeloperoxidase (MPO) Test, a Powerful Biomarker for Inflammation and its Role in Major Cardiac Events
Cleveland HeartLab Inc. (CHL), the premier cardiovascular disease (CVD) management company, announced today that a new patent for Myeloperoxidase (MPO) testing has been issued, U.S. Patent No. 9,575,065.
Introducing the Inaugural Medical Capital Innovation Competition
The Global Center for Health Innovation (GCHI), Cuyahoga County, BioEnterprise, and HIMSS (Healthcare Information and Management Systems Society) are pleased to announce the inaugural Medical Capital Innovation Competition - All Things Data in Healthcare -- a two-day event to be held in the HIMSS Innovation Center at the GCHI, Cleveland, OH, April 25-26, 2017. The Medical Capital Innovation Competition is open to and encourages participation from professional and collegiate teams. $100,000 in prizes, mentoring, and access to business advisors, including world-class healthcare systems and collaborators, will be awarded.
Surgical startup poised to enter market
Cleveland-based surgical navigation startup Centerline Biomedical Inc. is gearing up to enter the market in 2017 with its GPS-like system that provides 3-D guidance during endovascular surgery.
Cleveland Clinic doctors perform groundbreaking stroke surgery
The Cleveland Clinic has performed what it calls the "first deep brain stimulation surgery for stroke recovery," which it says is part of an ongoing clinical trial assessing the procedure's potential to improve movement in patients recovering from stroke.
Ringing in the New Year: Medical Innovations for 2017
What exciting new medical developments can we look forward to in 2017? To answer this question, the Cleveland Clinic assembled a group of more than 100 physicians and leading researchers, who identified the top 10 medical innovations anticipated to have the greatest impact. The final list was unveiled at the Cleveland Clinic's annual Medical Innovation Summit.1
Experimental transcatheter tricuspid stent implanted into patient at Cleveland Clinic
A new transcatheter tricuspid valved stent was successfully implanted into a patient at the Cleveland Clinic to treat tricuspid regurgitation, a disease grossing billions of dollars in treatments annually.